Schedule a Meeting
Download Brochure
Table of Content
April 2025
Principal Consultant
Reviewed By
The diabetes management technologies market is expected to see strong growth by 2034, thanks to ongoing progress in glucose monitoring tools, insulin delivery systems, and digital health platforms that help improve patient care. More people are looking for ways to manage their condition on their own, which is adding to the market’s momentum. At the same time, rapid advances in technology and the shift toward digital healthcare are making it easier for patients to adopt these tools. There's also a growing need for more personalized solutions, which is pushing the market even further.
Diabetes technology management comprises digital products such as software and devices. Digital products facilitate blood glucose monitoring, ease treatments, and track lifestyle. The increase in diabetes cases globally has enhanced innovations in emerging management technologies. Increasing rates of diabetes among the aging population are fueling the demand for diabetes technology management. The adoption of telehealth is transforming healthcare into a digital landscape. Its growing application for remote consultations, real-time monitoring, and patient-centric care is fueling innovations in edge digital management technologies. Diabetes is common in the geriatric population. Manufacturers are trying to make management easy and convenient using new diabetes technology management.
AI algorithms in diabetes technology management can analyze patient data (blood glucose levels, lifestyle factors) to predict future blood glucose fluctuations and potential complications, allowing for protective interventions. Optimized insulin dosage is a type of AI integration in diabetes technology management that can adjust insulin dosages based on real-time glucose readings, leading to better glycemic control. Diabetic retinopathy screening is also an AI algorithm that analyzes images to detect early signs of diabetic retinopathy, a leading cause of vision loss in people with diabetes. The most important CGMs help individuals better understand their blood sugar patterns and make informed decisions about diabetes technology management.
Increased number of diabetic patients and technological advancements in its treatment
The diabetes technology management market has expanded with a greater number of patients increasing globally with type 1 and type 2 diabetes mellitus. The rising global prevalence of diabetes was over 500 million adults in 2021, projected to hit 780 million by 2034. There are advancements in technology that make managing the condition easier and more precise. Diabetes technology management, a subset including apps and wearables, is expected to increase more in the forecast period. Tech advancements like AI algorithms, non-invasive sensors (still emerging) improve treatment outcomes. It helps the patients with convenience, fewer finger pricks, and more automation.
Higher cost of diabetes technological management devices
The high price tag of value-based care for diabetes technology management is the key impediment to the diabetes technology management market expansion. Sophisticated devices, such as insulin pens, insulin pumps, and digital self-monitoring devices, are costly, which maintains the adoption level low.
Advanced diabetic care and insurance partnerships
Diabetes care innovations are patient-centered and personalized and raising the need for self-management technologies. Disease prevalence and hospitalization are the drivers for the need for health claims and financial support. The growth in digital health solutions and value-based care also creates this need. Healthcare infrastructure is working together with large insurers in a bid to increase coverage of diabetes technology management. They are setting reimbursement policies to allow for the utilization of new technologies and guarantee quality care. This cooperation can increase the availability of diabetes care and encourage research and innovation.
The continuous glucose monitoring system segments dominated the diabetes technology management market in 2024 and are likely to increase more due to convenience and real-time tracking demand by patients. Smart insulin pumps and continuous glucose monitors make glucose tracking seamless, further enhancing diabetes care. Non-invasive technology and increased connectivity to mobile applications reinforce the segment.
The non-technological diabetic devices segment is expected to grow at the fastest rate in the market during the forecast period. The portable segment will also expand on the basis of its ease of use, portability, and affordability. The products, including blood glucose test strips and glucose meters, enable patients to achieve rapid, point-of-care glucose testing, thus being best suited for the patients in need of convenience but not for continuous monitoring.
The diabetic technology management segment dominated the diabetes technology management market in 2024 and is expected to grow further as required due to the demand for continuous monitoring and real-time tracking of data for convenience. Through this device, users can easily track their glucose levels throughout the day, improving the management of the disease called glycemic control. The growing use of non-invasive, easy-to-use technologies and further developments in device integration to mobile apps and smart features have also contributed to the segment's superiority.
The handheld device segment is expected to grow at a faster rate in the forecast period because of its affordability, high portability, and ease of use. These glucose meters and blood glucose test kits offer quick glucose readings to patients while they are on the go, hence offering perfect convenience for patients who do not want to have a continuous monitoring system. They are important in especially low-resource health systems where cost-effective healthcare options are critical; they complement wearables with a more focused way of managing diabetes on a daily basis.
The hospital segment dominated the diabetes technology management market with the largest share in 2024. Hospitals continue to be the most important centers for the performance of diagnostic testing, advanced treatment, and monitoring of patients having severe or complex diabetes. The presence of novel digital diabetes management applications in the hospital space, such as continuous glucose monitoring (CGM) systems and smart insulin pumps, allows real-time and streamlined, accurate glucose tracking during intensive care and hospital-based diabetes treatment.
The home setting segment is observed to grow at the fastest rate during the forecast period. This segment's growth is due to the rising inclination toward the use of convenient, at-home diabetes management solutions. Our patient population now has increasing access to methods that allow them to self-monitor and manage their condition, avoiding frequent visits to hospitals.
North America dominated the diabetes technology management market in 2024. This is due to the presence of key players in the region and the increase in the population suffering from the disease. This market is further driven by several strategies by these players. For instance, Lingo was launched in September 2024. It's the first over-the-counter continuous glucose monitoring system in the U.S. due to the rising incidence of diabetes in the country and growing demand for advanced devices for real-time monitoring, glycemic control, and improved patient convenience. For instance, the International Diabetes Federation (IDF) states that in 2024, there were about 32.2 million people living with diabetes in the U.S., with projections for this number to reach 34.7 million by the year 2034.
The U.S. market held the largest share in the North America region. This can be attributed to the rising prevalence of diabetes in the country and the growing demand for advanced devices to enable real-time monitoring, improve glycemic control, and enhance patient convenience. For instance, according to the International Diabetes Federation (IDF), approximately 32.2 million people in the U.S. were living with diabetes as of 2024, a number projected to rise to 34.7 million by 2034.
Formerly, healthcare was not something people used to worry about, and one main reason for that was their lifestyle, which was healthier and much more active. We see that decline now, but since the problems have surged, so have the treatments. Now people are more self-aware and take health issues seriously. One reason for the treatment surge is the technological advancements in healthcare. And this upscale of technology is clearly visible in diabetes management as well.
Canadians have incorporated this kind of technology very well into their lifestyle. Diabetes, being the most common problem, has its treatments that are technology-related as well. This includes two types of devices, which help in monitoring blood glucose levels and are seen on a monitor: intermittently scanned continuous glucose monitoring (isCGM) systems and traditional glucometers. The use of traditional glucometers is still excessive as it is easy to use and isCGM systems are still trying to make its way in people’s life as it is a much newer innovation.
Europe is expected to be the fastest-growing region in the diabetes technology management market in 2024. Technological innovations have increased over the period of time and resulted in diabetes friendly devices for safer and more precise administration of insulin. European countries are enduring immensely from the high demand for diabetes expenditure, due to its rising prevalence. Medtronic announced its first integrated smart insulin pen. The Medtronic Integrated Insulin Pen provides glucose intake readings for patients with insulin dose information to regulate their blood glucose levels.
Every year, 21,500 kids are added to the type-1 diabetic population diseased pool. These numbers show us that approximately 9% of the total healthcare expenditure is spent on diabetes in Europe.
The UK market is gaining considerable attention with increasing incidence rates of diabetes, availing to cutting-edge healthcare infrastructure, and innovation of new devices in the region. For example, in June 2024, Insulet announced the full commercial transformation of its Omnipod 5 Automatic Insulin Delivery System in the UK and other European countries, which now has a new feature of expanded integration with advanced glucose sensors. This technology helps alert the patient whenever the glucose levels are high and need to be controlled.
Germany is expected to grow at the fastest rate in the upcoming years. Germany's digital diabetes management industry has stabilized its growth, supported by strong healthcare infrastructure and continuous advancements in diabetes monitoring devices. The high prevalence of diabetes also boosts growth. Approximately 6.2 million people were living with diabetes in Germany in 2021, and this is expected to rise to 6.5 million by 2034, according to the International Diabetes Federation. Germany, still being a health-conscious country they has skillfully reduced the surge of diabetic patients when compared to other European countries.
The Asia Pacific diabetes technology management market is expected to experience a notable growth rate. The major driver behind this growth is high incidence rates in countries such as India and China, which are significant contributors to the global diabetes population. The market demand is being boosted by increased and increasing adoption of sophisticated technology such as continuous glucose monitoring (CGM) systems, along with smart insulin devices and increasing awareness regarding these digital health solutions in managing diabetes. Improvement in healthcare infrastructure and higher disposable income are pushing forward the market expansion, along with several supportive government initiatives to promote diabetes technology management.
It is soon to be expected that the market for diabetes technology management in China will experience some remarkable growth rates from 2025-2034. One of the major reasons for this increased demand for diabetes technology management is, for instance, that China is home to one of the largest populations of diabetic patients in the world. These patients create a lucrative demand for advanced management solutions such as continuous glucose monitors (CGMs), smart insulin delivery devices, and mobile health applications for easy access. This is in addition to the increased focus of the government on health rectifications, with more funding put into the digital health architecture, facilitating the gigantic comprehension of innovative technologies in this market.
By Product Insight
By Type Insights
By End-User Insights
By Region
April 2025
April 2025
April 2025
March 2025